​

Benitec Biopharma Ownership | Who Owns Benitec Biopharma?

OverviewForecastRevenueFinancialsChart

Benitec Biopharma Ownership Summary

Benitec Biopharma is owned by 21.00% institutional investors, 2.71% insiders, and 76.29% retail investors. Suvretta capital management is the largest institutional shareholder, holding 27.28% of BNTC shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 3.50% of its assets in Benitec Biopharma shares.

BNTC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBenitec Biopharma21.00%2.71%76.29%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Suvretta capital management9.88M27.28%$138.57M
Adage capital partners gp1.97M5.45%$27.67M
Franklin resources2.20M5.29%$29.60M
Vanguard group1.17M2.83%$15.82M
Nantahala capital management1.04M2.50%$13.99M
Blackrock funding, inc. /de992.35K2.39%$13.37M
Silverarc capital management731.72K1.76%$9.86M
Infinitum asset management500.00K1.38%$7.01M
Geode capital management453.38K1.09%$6.11M
Schonfeld strategic advisors260.42K0.72%$3.65M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lion point capital, lp62.00K4.94%$869.86K
Suvretta capital management9.88M3.55%$138.57M
Silverarc capital management731.72K1.37%$9.86M
Infinitum asset management500.00K1.29%$7.01M
Empery asset management, lp55.44K0.66%$746.78M
Nantahala capital management1.04M0.46%$13.99M
Awm investment company282.98K0.37%$3.81M
Myda advisors70.00K0.21%$982.10K
Longaeva partners37.54K0.08%$526.64K
Adage capital partners gp1.97M0.04%$27.67M

Top Buyers

HolderShares% AssetsChange
Silverarc capital management731.72K1.37%455.45K
Nantahala capital management1.04M0.46%200.28K
Vanguard group1.17M0.00%182.64K
Awm investment company282.98K0.37%100.00K
Simplify asset management151.16K0.03%72.44K

Top Sellers

HolderShares% AssetsChange
Franklin resources2.20M0.01%-392.33K
Marshall wace, llp---43.00K
Eam investors---37.81K
Goldman sachs group174.04K0.00%-20.32K
Qube research---19.00K

New Positions

HolderShares% AssetsChangeValue
Empery asset management, lp55.44K0.66%55.44K$746.78M
Hrt financial lp13.29K0.00%13.29K$178.00K
Jane street group12.43K-12.43K$167.37K
Sg americas securities8.23K0.00%8.23K$111.00K
Russell investments group5.62K0.00%5.62K$78.78K

Sold Out

HolderChange
Sbi securities-1.00
Srs capital advisors-24.00
Simplex trading-72.00
Eversource wealth advisors-148.00
Acadian asset management-1.82K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202544-20.00%8,720,874-62.34%210.51%26-23.53%1025.00%
Sep 30, 202533-37.74%5,883,256-74.00%160.47%19-45.71%6-45.45%
Jun 30, 20255651.35%22,685,5313.62%581.83%3742.31%12100.00%
Mar 31, 20253620.00%21,891,36615.23%560.77%258.70%650.00%
Dec 31, 20243020.00%18,997,89738.52%860.52%2391.67%4-50.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Franklin Biotechnology Discv A(acc)USD1.20M3.50%-
HBM Healthcare Investments AG Ord1.19M3.47%-
Franklin Biotechnology Discovery A995.15K2.90%-
Vanguard Total Stock Mkt Idx Inv627.79K1.83%-
Janus Henderson Hrzn Biotec E2 USD433.14K1.26%8.89K
iShares Russell 2000 ETF344.58K1.00%344.58K
Simplify Health Care ETF328.38K0.96%-
Vanguard Institutional Extnd Mkt Idx Tr272.51K0.79%-
MEDICAL BioHealth EUR Acc195.16K0.57%89.00
Fidelity Small Cap Index149.54K0.44%1.54K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 23, 2025SUVRETTA CAPITAL MANAGEMENT, LLC Buy$547.41K
Dec 29, 2025SUVRETTA CAPITAL MANAGEMENT, LLC Buy$155.73K
Dec 26, 2025SUVRETTA CAPITAL MANAGEMENT, LLC Buy$187.59K
Dec 29, 2025SUVRETTA CAPITAL MANAGEMENT, LLC Buy$884.35K
Dec 26, 2025SUVRETTA CAPITAL MANAGEMENT, LLC Buy$32.96K

Insider Transactions Trends

DateBuySell
2025 Q414-
2025 Q16-
2024 Q410-
2024 Q3--
2024 Q2--

BNTC Ownership FAQ

Who Owns Benitec Biopharma?

Benitec Biopharma shareholders are primarily institutional investors at 21.00%, followed by 2.71% insiders and 76.29% retail investors. The average institutional ownership in Benitec Biopharma's industry, Biotech Stocks , is 381.47%, which Benitec Biopharma falls below.

Who owns the most shares of Benitec Biopharma?

Benitec Biopharma’s largest shareholders are Suvretta capital management (9.88M shares, 27.28%), Adage capital partners gp (1.97M shares, 5.45%), and Franklin resources (2.2M shares, 5.29%). Together, they hold 38.02% of Benitec Biopharma’s total shares outstanding.

Does Blackrock own Benitec Biopharma?

BlackRock is not among the top 10 institutional shareholders of Benitec Biopharma.

Who is Benitec Biopharma’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is Benitec Biopharma’s biggest shareholder by percentage of total assets invested, with 4.94% of its assets in 62K Benitec Biopharma shares, valued at 869.86K$.

Who is the top mutual fund holder of Benitec Biopharma shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of Benitec Biopharma shares, with 3.50% of its total shares outstanding invested in 1.2M Benitec Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools